A phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection in women in sub-Saharan Africa: baseline findings

Bibliographische Detailangaben

Veröffentlicht in:	Journal of acquired immune deficiency syndromes (1999) 2021-02
Hauptverfasser:	Mgodi, Nyaradzo M, Takuva, Simbarashe, Edupuganti, Srilatha, Karuna, Shelly, Andrew, Philip, Lazarus, Erica, Garnett, Precious, Shava, Emily, Mukwekwerere, Pamela G, Kochar, Nidhi, Marshall, Kyle, Rudnicki, Erika, Juraska, Michal, Anderson, Maija, Karg, Carissa, Tindale, India, Greene, Elizabeth, Luthuli, Nandisile, Baepanye, Kagisho, Hural, John, Gomez Lorenzo, Margarita M, Burns, David, Miner, Maurine D., Ledgerwood, Julie, Mascola, John R., Donnell, Deborah, Cohen, Myron S., Corey, Lawrence
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!